Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Varsha S. Jagtap is active.

Publication


Featured researches published by Varsha S. Jagtap.


Endocrine Practice | 2011

Tumor-induced osteomalacia: a single center experience.

Varsha S. Jagtap; Vijaya Sarathi; Anurag Lila; Gaurav Malhotra; Shilpa Sankhe; Tushar Bandgar; Padmavathy Menon; Nalini S. Shah

OBJECTIVE To describe the clinical presentation, localization modalities, and management of patients with tumor-induced osteomalacia (TIO). METHODS We performed a retrospective analysis of case records of patients diagnosed with TIO between January 1996 and March 2010 at our institution in Mumbai, India. RESULTS Nine patients (6 female and 3 male) with a mean age of 37.5 ± 17.5 years with biochemical and imaging evidence of TIO were included in the study. Overall, patients presented with proximal muscle weakness and pain. Three patients had neurofibromatosis 1, one had isolated schwannoma, and one had epidermal nevus syndrome. The mean delay in diagnosis was 7.67 years. Biochemical studies revealed normal serum calcium (mean, 9.2 ± 0.8 mg/dL), low serum phosphorus (mean, 1.36 ± 0.54 mg/dL), and low maximal tubular reabsorption of phosphorus factored for glomerular filtration rate (mean, 0.94 ± 0.49 mg/dL). Fibroblast growth factor-23 was increased in 3 of the patients without neurofibromatosis but was normal or near-normal in all the patients with neurofibromas. A fludeoxyglucose F 18 positron emission tomography (FDG PET) scan helped to localize the tumors in 4 of the 5 patients with diagnoses other than neurofibromatosis. Three patients underwent surgical excision and were cured. One patient underwent biopsy and partial excision. Histopathologic findings were suggestive of phosphaturic mesenchymal tumor, benign fibrous histiocytoma, nonossifying fibroma, and sciatic nerve schwannoma. CONCLUSION There is a well-known delay in the diagnosis of TIO. FDG PET is a useful modality for localization of tumors. Preoperative localization increases the odds for cure after surgical excision.


Clinical Endocrinology | 2014

Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET/CT vs somatostatin receptor-based functional scans: a series of nine patients.

Swati Jadhav; Rajeev Kasaliwal; Vikram Lele; Venkatesh Rangarajan; Piyush Chandra; Hina Shah; Gaurav Malhotra; Varsha S. Jagtap; Sweta Budyal; Anurag Lila; Tushar Bandgar; Nalini S. Shah

Localization of phosphatonin‐producing mesenchymal tumours in patients with primary tumour‐induced osteomalacia (pTIO) is challenging. Functional imaging plays an important role in the localization of these tumours.


Clinical Endocrinology | 2013

Volume interpolated 3D‐spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas

Rajeev Kasaliwal; Shilpa Sankhe; Anurag Lila; Sweta Budyal; Varsha S. Jagtap; Vijaya Sarathi; Harshal Kakade; Tushar Bandgar; Padmavathy Menon; Nalini S. Shah

Various techniques have been attempted to increase the yield of magnetic resonance imaging (MRI) for localization of pituitary microadenomas in corticotropin (ACTH)‐dependent Cushings syndrome (CS).


Endocrine Practice | 2013

Ectopic ACTH-secreting syndrome: a single-center experience.

Harshal Kakade; Rajeev Kasaliwal; Varsha S. Jagtap; Amol Bukan; Sweta Budyal; Shruti Khare; Anurag Lila; Tushar Bandgar; Padmavathy Menon; Nalini S. Shah

OBJECTIVE Ectopic adrenocorticotropic hormone (ACTH)-secreting syndrome (EAS) is a rare cause of ACTH-dependent endogenous hypercortisolism. The objective of this study was to analyze clinical, biochemical, and imaging characteristics; management strategies; and outcomes of EAS patients. METHOD We screened the records (1993-2012) of ACTH-dependent endogenous hypercortisolism cases managed at a tertiary care center. RESULTS Of the 218 patients, 17 were diagnosed with EAS. The median 8:00 AM serum cortisol was 36 μg/dL (11.4-82.7 μg/dL), and the median basal plasma ACTH was 156 pg/mL (53.5-468 pg/mL). Notably, ACTH levels below 100 pg/mL were found in 4 patients. Suspicious microadenoma was found on magnetic resonance imaging (MRI) of the pituitary in 5 patients, and all of them underwent transsphenoidal surgery (TSS). Inferior petrosal sinus sampling (IPSS) was performed in 8 patients, and the results were suggestive of a peripheral source in all 8. Computed tomography (CT) localized the lesion in 15/17 patients. In 2 patients with negative CTs, gallium DOTATATE positron emission tomography (PET) scans localized the lesion. Despite difficulties localizing bronchial carcinoids, the cure rate was high (72%). In contrast, thymic carcinoids were easily localized but had poor outcomes. CONCLUSION EAS cannot be ruled out on the basis of marginally elevated ACTH. In cases with an equivocal MRI pituitary finding, prior IPSS can help avoid unnecessary TSS. CT is a useful modality for localization of an ectopic source. Functional imaging may help in cases where anatomical imaging fails.


Indian Journal of Endocrinology and Metabolism | 2012

Renal manifestations of primary hyperparathyroidism.

Anurag Lila; Vijaya Sarathi; Varsha S. Jagtap; Tushar Bandgar; Padma S. Menon; Nalini S. Shah

Primary hyperparathyroidism (PHPT) is associated with nephrolithiasis and nephrocalcinosis. Hypercalciuria is one of the multiple factors that is implicated in the complex pathophysiology of stone formation. The presence of a renal stone (symptomatic or asymptomatic) categorizes PHPT as symptomatic and is an indication for parathyroid adenomectomy. Progression of nephrocalcinosis is largely reversible after successful surgery, but the residual risk persists. PHPT is also associated with declining renal function. In case of asymptomatic mild PHPT, annual renal functional assessment is advised. Guidelines suggest that an estimated glomerular filtration rate (eGFR) < 60 ml / minute / 1.73 m2 is an indication for parathyroid adenomectomy. This article discusses how to monitor and manage renal stones and other related renal parameters in case of PHPT.


The Journal of Clinical Endocrinology and Metabolism | 2014

Radiofrequency Ablation, an Effective Modality of Treatment in Tumor-Induced Osteomalacia: A Case Series of Three Patients

Swati Jadhav; Rajeev Kasaliwal; Nitin Shetty; Suyash Kulkarni; Krantikumar Rathod; Bhavesh Popat; Harshal Kakade; Amol Bukan; Shruti Khare; Sweta Budyal; Varsha S. Jagtap; Anurag Lila; Tushar Bandgar; Nalini S. Shah

CONTEXT Tumor-induced osteomalacia is curable if the tumors can be totally excised. However, when the tumors are present in locations that make surgery disproportionately risky, the need for less invasive strategies like radiofrequency ablation (RFA) is realized. PATIENTS AND METHODS We describe three patients with suspected tumor-induced osteomalacia who were treated in our department between 2006 and 2013 with tumors in surgically difficult locations and were subjected to single or multiple sessions of RFA. The response was documented in terms of symptomatic improvement, phosphorus normalization, and follow-up (99m)Technitium-labelled hydrazinonicotinyl-Tyr3-octreotide ((99m)Tc HYNIC TOC) scan. RESULTS Two of the three individuals, patient A (with a 1.5 × 1.2-cm lesion in the head of the right femur) and patient B (with a 1.3 × 1.2-cm lesion on the endosteal surface of the shaft of the left femur), achieved complete remission with single sessions of RFA. Three months after the procedure, (99m)Tc HYNIC TOC scans revealed the absence of uptake at the previous sites, corroborating with the clinical improvement and phosphorus normalization. Patient C had a large 5.6 × 6.5-cm complex lesion in the lower end of the left femur with irregular margins, loculations, and bone grafts placed in previous surgery. He failed to achieve remission after multiple sessions of RFA due to the complex nature of the lesion, although the tumor burden was reduced significantly as documented on serial (99m)Tc HYNIC TOC scans. CONCLUSIONS Although surgery remains the treatment of choice, RFA could be an effective, less invasive, and safe modality of treatment in judiciously selected patients.


Endocrine Practice | 2013

An Objective Olfactory Evaluation and Its Correlation with Magnetic Resonance Imaging Findings in Asian Indian Patients with Idiopathic Hypogonadotropic Hypogonadism

Varsha S. Jagtap; Vijaya Sarathi; Anurag Lila; Sandhya Nair; Amol Bukan; Shilpa Sankhe; Venkatesh Shivane; Tushar Bandgar; Padmavathy Menon; Nalini S. Shah

OBJECTIVE Idiopathic hypogonadotropic hypogonadism (IHH) can be associated with subnormal sense of smell. The objective of our study was to determine if there is a correlation between the olfactory phenotype (clinical smell test) of IHH patients and structural abnormalities in the olfactory apparatus on magnetic resonance imaging (MRI). METHODS This was a single-center prospective case control study. Forty-one IHH patients underwent a brief University of Pennsylvania Smell Identification Test (UPSIT) and an MRI of the olfactory apparatus. The size of the olfactory sulcus and bulb were quantified and compared with the normative data of 40 controls. Agreement between UPSIT and MRI results was assessed using the kappa index. RESULTS MRI showed that the olfactory apparatus was normal in 17 patients, hypoplastic in 14, and aplastic in 10. All 13 patients who complained of anosmia and 12 of 28 patients who reported normosmia had a low UPSIT score. Thus, 25 patients had Kallmann syndrome (KS) and 16 were normosmic IHH (nIHH). MRI revealed abnormalities in 68% of KS and 37.5% of nIHH patients. The MRI abnormalities in KS patients were aplasia (56%) and hypoplasia (44%). All 6 nIHH patients with abnormal MRI had hypoplasia. A significant positive correlation (r = 0.61; P<.01) between olfactory bulb volume (from MRI) and smell-test score was found, and there was good agreement (kappa index, 0.72) between anosmia and the presence of an aplastic olfactory apparatus. CONCLUSION Self-reporting of the sense of smell significantly underestimates olfactory phenotype; hence, we recommend an objective smell test to distinguish KS from nIHH. Olfactory phenotype correlates well with MRI quantification of the olfactory apparatus in IHH.


Indian Journal of Endocrinology and Metabolism | 2011

Prevalence of upper airway obstruction in patients with apparently asymptomatic euthyroid multi nodular goitre

Sunil K. Menon; Varsha S. Jagtap; Vijaya Sarathi; Anurag Lila; Tushar Bandgar; Padmavathy Menon; Nalini S. Shah

Aims: To study the prevalence of upper airway obstruction (UAO) in “apparently asymptomatic” patients with euthyroid multinodular goitre (MNG) and find correlation between clinical features, UAO on pulmonary function test (PFT) and tracheal narrowing on computerised tomography (CT). Materials and Methods: Consecutive patients with apparently asymptomatic euthyroid MNG attending thyroid clinic in a tertiary centre underwent clinical examination to elicit features of UAO, PFT, and CT of neck and chest. Statistical Analysis Used: Statistical analysis was done with SPSS version 11.5 using paired t-test, Chi square test, and Fishers exact test. P value of <0.05 was considered to be significant. Results: Fifty-six patients (52 females and four males) were studied. The prevalence of UAO (PFT) and significant tracheal narrowing (CT) was 14.3%. and 9.3%, respectively. Clinical features failed to predict UAO or significant tracheal narrowing. Tracheal narrowing (CT) did not correlate with UAO (PFT). Volume of goitre significantly correlated with degree of tracheal narrowing. Conclusions: Clinical features do not predict UAO on PFT or tracheal narrowing on CT in apparently asymptomatic patients with euthyroid MNG.


Clinical Endocrinology | 2016

Spectrum of phenotype and genotype of congenital isolated hypogonadotropic hypogonadism in Asian Indians.

Sandhya Nair; Swati Jadhav; Anurag Lila; Varsha S. Jagtap; Amol Bukan; Reshma Pandit; Alka Ekbote; Mala Dharmalingam; Prasanna Kumar; Pramila Kalra; Pramod Gandhi; Rama Walia; Shilpa Sankhe; Vijaya Raghavan; Vyankatesh Shivane; Padma S. Menon; Tushar Bandgar; Nalini S. Shah

Congenital isolated hypogonadotropic hypogonadism (IHH) is caused due to defect in GnRH neuronal development, migration and action. Although genetic aetiology of IHH is increasingly being studied, Asian Indian data on phenotypic spectrum and genetic basis are scarce.


Endocrine Practice | 2014

Pheochromocytoma and tetralogy of Fallot: a rare but potentially dangerous combination.

Rajeev Kasaliwal; Sarathi; Reshma Pandit; Budyal; Amol Bukan; Harshal Kakade; Varsha S. Jagtap; Anurag Lila; Tushar Bandgar; Padmavathy Menon; Nalini S. Shah

OBJECTIVE To describe a case of pheochromocytoma (PHEO) with tetralogy of Fallot (TOF) and discuss the difficulties encountered during the management of this patient, with a review of the literature. METHODS We report the clinical course, imaging, and management issues of our patient and review relevant literature. RESULTS A 14-year-old female who was known to have TOF presented with classical paroxysmal symptoms and worsening dyspnea. She was diagnosed as having epinephrine-secreting PHEO based on biochemical, radiologic, and functional imaging. She was treated with an α-1 blocker for control of paroxysms but developed severe cyanotic spells. She required addition of a calcium-channel blocker for control of the paroxysms and underwent successful cardiac repair. CONCLUSION Treatment of the combination of cyanotic congenital heart disease (CCHD) and PHEO requires an individualized and multidisciplinary approach with judicious use of available medications. This is the first case of uncorrected TOF and epinephrine-secreting PHEO. Our case also reiterates the need for further studies to better understand the pathophysiologic link between PHEO/paraganglioma and CCHD.

Collaboration


Dive into the Varsha S. Jagtap's collaboration.

Top Co-Authors

Avatar

Nalini S. Shah

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Anurag Lila

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Tushar Bandgar

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Sweta Budyal

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Amol Bukan

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Rajeev Kasaliwal

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Harshal Kakade

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shruti Khare

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Swati Jadhav

King Edward Memorial Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge